Study of V117957 in Overactive Bladder Syndrome
Condition: Overactive Bladder Syndrome Interventions: Drug: V117957; Drug: Placebo Sponsors: Imbrium Therapeutics; Purdue Pharma LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
Conditions: Overactive Bladder; Overactive Bladder Syndrome Interventions: Drug: Oral Solifenacin 5mg; Device: Transcutaneous Posterior Tibial Nerve Stimulation (TTNS) Sponsor: Ege University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials